HOME >> BIOLOGY >> NEWS
Diabodies act as guided missiles targeted to mammary tumor growth

A mini-antibody bearing a payload of tumor-busting radiation thwarts the growth of human breast cancer in laboratory animals, according to research published in the September 1 issue of the journal Cancer Research.

The research shows that a diabody, an antibody surrogate just one third the size of native antibodies, can be used effectively as a targeting vehicle for radioimmunotherapy, said Gregory Adams, Ph.D., associate member of the Medical Science Division, Fox Chase Cancer Center, Philadelphia, Pa.

Diabodies are genetically engineered dimeric proteins produced in E. coli bacteria that contain the antigen-recognizing portion of antibodies formed by immune system cells to combat disease. The mini-antibody developed by Adams and colleagues, C6.5K-A, is a protein substitute for larger, naturally produced antibodies that specifically target the HER2/neu human tumor-associated antigen. When loaded with the beta-emitting radioisotope yttrium-90, C6.5K-A significantly inhibits the growth rate of human breast tumor xenografts in mice.

"The diabodies bound to the HER2 receptor produced by certain breast tumor cells." said Adams, the lead author on the paper. "Imaging indicated that the diabody was concentrated in the mammary tumors and in the kidney where it was excreted from the body."

Since diabodies are so much smaller than native antibodies, the genetically engineered protein is cleared much quicker from the body, Adams said. However, the affinity that the diabody has for its antigen target is so great that a significant amount of the cell-killing radioactive protein lodges in the mammary tumor cells.

"The dimeric C6.5K-A binds to its target antigen 40 times more tenaciously than its individual monomeric components, thus promoting prolonged retention in antigen-laden tumors. At the same time, its small size enables it to efficiently find and penetrate these tumors," Adams said.

Using the HER2 receptor protein o
'"/>

Contact: Russell Vanderboom, PhD
vanderboom@aacr.org
215-440-9300
American Association for Cancer Research
1-Sep-2004


Page: 1 2

Related biology news :

1. Nerve cells guided to repair spinal damage: Technique
2. Traditional Inuit ice treks guided from space
3. UN development work guided from space
4. Image-guided Therapies
5. Science reviewer calls anti-environmental book dangerous and misguided
6. Stem cells guided down bloods developmental pathway
7. Improved guidance systems for missiles will reduce collateral damage
8. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
9. Safety of isoflavones in dietary supplements targeted by Illinois initiative
10. Second generation targeted antibodies - Its all in the binding
11. Study identifies which patients can benefit from targeted lung cancer drug and why

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/11/2020)... HOUSTON (PRWEB) , ... May 11, 2020 , ... ... generation remote monitoring software platform for patients with implanted cardiac devices. The Octagos ... data using one portal. The software greatly simplifies the management of remote transmissions ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor. The ... companion diagnostics industries. Flagship and Corritori are taking a collaborative approach to empower ...
(Date:4/30/2020)... ... April 28, 2020 , ... Ever a responsive and ... providing timely and critical information to life science organizations as they navigate the ... concerns. , “Providing the most up-to-date actionable guidance and information has been a ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... ANN ARBOR, Mich. (PRWEB) , ... April 21, ... ... help clinical researchers continue their work through COVID-19. Many clinical trial teams are ... their work online. Ripple Science wants to help researchers continue their research during ...
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , leading ... 200,000 SneakPeek Early Gender DNA Tests sold in March, just months after ... as an ecommerce product, where a mom could order her kit online, collect a ...
(Date:4/1/2020)... ... March 30, 2020 , ... ... product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology within ... provides continual antimicrobial activity against microorganisms for up to 90 days. , In ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... developed a method using its revolutionary NEXTGENPCR endpoint thermocycler and consumables that ... reaction volumes, increased samples per run, and standard, affordable laboratory equipment, a ...
Breaking Biology Technology:
Cached News: